The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion
Open accessAbstract
Recent outbreaks of severe acute respiratory syndrome and Middle East respiratory syndrome, along with the threat of a future coronavirus-mediated pandemic, underscore the importance of finding ways to combat these viruses. The trimeric spike transmembrane glycoprotein S mediates entry into host cells and is the major target of neutralizing antibodies. To understand the humoral immune response elicited upon natural infections with coronaviruses, we structurally characterized the SARS-CoV and MERS-CoV S glycoproteins in complex with neutralizing antibodies isolated from human survivors. Although the two antibodies studied blocked attachment to the host cell receptor, only the anti-SARS-CoV S antibody triggered fusogenic conformational changes via receptor functional mimicry. These results provide a structural framework for understanding coronavirus neutralization by human antibodies and shed light on activation of coronavirus membrane fusion, which takes place through a receptor-driven ratcheting mechanism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Protection is thought to be mediated by neutralizing antibodies against the S protein (7, 8)”
From An Alphavirus -derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates (2020) · cites this paper as [7]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,882
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047337 · Cited by 16,463
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115
cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
Punjani, A., Rubinstein, J. L., Fleet, D. J., & Brubaker, M. A. (2017) · Nature Methods · doi:10.1038/nmeth.4169 · Cited by 11,626
Inference of Macromolecular Assemblies from Crystalline State
Krissinel, E., & Henrick, K. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.05.022 · Cited by 10,007
MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy
Zheng, S. Q., Palovcak, E. J., Armache, J., Verba, K. A., Cheng, Y., & Agard, D. A. (2017) · Nature Methods · doi:10.1038/nmeth.4193 · Cited by 7,496
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkòczi, G., Chen, V. B., Davis, I., Echols, N., Headd, J. J., Hung, L., Kapral, G. J., Grosse‐Kunstleve, R. W., et al. (2012) · International Tables for Crystallography · doi:10.1107/97809553602060000865 · Cited by 7,334
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 587
A Survey on Applications of Artificial Intelligence in Fighting Against COVID-19
Chen, J., Li, K., Zhang, Z., Li, K., & Yu, P. S. (2021) · ACM Computing Surveys · doi:10.1145/3465398 · Cited by 154
Li, W., Chen, Y., Prévost, J., Ullah, I., Lu, M., Gong, S. Y., Tauzin, A., Gasser, R., Vézina, D., Anand, S. P., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110210 · Cited by 128
Conformational transition of SARS-CoV-2 spike glycoprotein between its closed and open states
Gür, M., Taka, E., Yilmaz, S. Z., Kılınç, C., Aktas, U., & Gölcük, M. (2020) · The Journal of Chemical Physics · doi:10.1063/5.0011141 · Cited by 126
Mercurio, I., Tragni, V., Busto, F., Grassi, A., & Pierri, C. L. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03580-1 · Cited by 129
Neutralizing Aptamers Block S/RBD‐ACE2 Interactions and Prevent Host Cell Infection
Liu, X., Wang, Y., Wu, J., Qi, J., Zeng, Z., Wan, Q., Chen, Z., Manandhar, P., Cavener, V. S., Boyle, N. R., et al. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202100345 · Cited by 123
Hunt, A. C., Case, J. B., Park, Y., Cao, L., Wu, K., Walls, A. C., Liu, Z., Bowen, J. E., Yeh, A. H.-W., Saini, S., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abn1252 · Cited by 121
Self-citationMolecular Investigation of SARS–CoV-2 Proteins and Their Interactions with Antiviral Drugs
Calligari, P. A., Bobone, S., Ricci, G., & Bocedi, A. (2020) · Viruses · doi:10.3390/v12040445 · Cited by 123
SARS-CoV-2 spike engagement of ACE2 primes S2′ site cleavage and fusion initiation
Yu, S., Zheng, X., Zhou, B., Li, J., Chen, M., Deng, R. X., Wong, G., Lavillette, D., & Meng, G. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2111199119 · Cited by 130
He, L., Lin, X., Wang, Y., Abraham, C., Sou, C., Ngo, T., Zhang, Y., Wilson, I. A., & Zhu, J. (2021) · Science Advances · doi:10.1126/sciadv.abf1591 · Cited by 121
Fruitful Neutralizing Antibody Pipeline Brings Hope To Defeat SARS-Cov-2
Renn, A., Fu, Y., Hu, X., Hall, M. D., & Simeonov, A. M. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.07.004 · Cited by 117
Approaches and Challenges in SARS-CoV-2 Vaccine Development
Dagotto, G., Yu, J., & Barouch, D. H. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.08.002 · Cited by 103
Potential neutralizing antibodies discovered for novel corona virus using machine learning
Magar, R., Yadav, P., & Barati Farimani, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-84637-4 · Cited by 114
Trezza, A., Iovinelli, D., Santucci, A., Prischi, F., & Spiga, O. (2020) · Scientific Reports · doi:10.1038/s41598-020-70863-9 · Cited by 115
Liu, R., He, L., Hu, Y., Luo, Z., & Zhang, J. (2020) · Chemical Science · doi:10.1039/d0sc03920a · Cited by 111
An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections
Dang, H. V., Chan, Y., Park, Y., Snijder, J., Silva, S. C. D., Vu, B. K., Yan, L., Feng, Y.-R., Rockx, B., Geisbert, T. W., et al. (2019) · Nature Structural & Molecular Biology · doi:10.1038/s41594-019-0308-9 · Cited by 110
Self-citationAptamer-based biosensors for virus protein detection
Lou, B., Liu, Y., Shi, M., Chen, J., Li, K., Tan, Y., Chen, L., Wu, Y., Wang, T., Liu, X., et al. (2022) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2022.116738 · Cited by 112
Carino, A., Moraca, F., Fiorillo, B., Marchianò, S., Sepe, V., Biagioli, M., Finamore, C., Bozza, S., Francisci, D., Distrutti, E., et al. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.572885 · Cited by 113
Breiman, A., Ruvoën‐Clouet, N., & LePendu, J. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008556 · Cited by 106
Wrapp, D., & McLellan, J. S. (2019) · Journal of Virology · doi:10.1128/jvi.00923-19 · Cited by 106
Sun, D., Sang, Z., Kim, Y. J., Xiang, Y., Cohen, T., Belford, A. K., Huet, A., Conway, J. F., Sun, J., Taylor, D. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24963-3 · Cited by 96
Virus vaccines: proteins prefer prolines
Sanders, R. W., & Moore, J. P. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.02.002 · Cited by 97
Distinct Roles for Sialoside and Protein Receptors in Coronavirus Infection
Qing, E., Hantak, M. P., Perlman, S. M., & Gallagher, T. (2020) · mBio · doi:10.1128/mbio.02764-19 · Cited by 100
Potential drug targets of SARS-CoV-2: From genomics to therapeutics
Shamsi, A., Mohammad, T., Anwar, S., Amani, S., Khan, M. S., Husain, F. M., Rehman, M. T., Islam, A., & Hassan, M. I. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.02.071 · Cited by 104
Glycans of SARS-CoV-2 Spike Protein in Virus Infection and Antibody Production
Zhao, X., Chen, H., & Wang, H. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.629873 · Cited by 103
Tse, L. V., Meganck, R. M., Graham, R. L., & Baric, R. S. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00658 · Cited by 101
Structure and immune recognition of the porcine epidemic diarrhea virus spike protein
Kirchdoerfer, R. N., Bhandari, M. A., Martini, O., Sewall, L. M., Bangaru, S., Yoon, K. J., & Ward, A. B. (2020) · Structure · doi:10.1016/j.str.2020.12.003 · Cited by 98
Conformational dynamics and allosteric modulation of the SARS-CoV-2 spike
Díaz-Salinas, M. A., Li, Q., Ejemel, M., Yurkovetskiy, L., Luban, J., Shen, K., Wang, Y., & Munro, J. B. (2022) · eLife · doi:10.7554/elife.75433 · Cited by 81
Tortorici, M. A., Walls, A. C., Joshi, A., Park, Y., Eguia, R. T., Miranda, M. C., Kepl, E., Dosey, A. M., Stevens‐Ayers, T., Boeckh, M. J., et al. (2022) · Cell · doi:10.1016/j.cell.2022.05.019 · Cited by 89
Self-citationHighly Conserved Homotrimer Cavity Formed by the SARS-CoV-2 Spike Glycoprotein: A Novel Binding Site
Kalathiya, U., Padariya, M., Mayordomo, M. Y., Lisowska, M. M., Nicholson, J., Singh, A. J., Bagiński, M., Fåhræus, R., Carragher, N. O., Ball, K. L., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051473 · Cited by 93
SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?
Chakraborty, S., Mallajosyula, V. V. A., Tato, C. M., Tan, G. S., & Wang, T. T. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.014 · Cited by 90
Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection
Labò, N., Ohnuki, H., & Tosato, G. (2020) · Cells · doi:10.3390/cells9071583 · Cited by 92
Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapy
Cruz-Teran, C. A., Tiruthani, K., McSweeney, M. D., Ma, A. L., Pickles, R. J., & Lai, S. K. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.004 · Cited by 90
The insert sequence in SARS-CoV-2 enhances spike protein cleavage by TMPRSSPreprint
Meng, T., Cao, H., Zhang, H., Kang, Z., Xu, D., Gong, H., Wang, J., Li, Z., Cui, X., Xu, H., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.08.926006 · Cited by 91
Karthik, K., Senthilkumar, T. M. A., Udhayavel, S., & Raj, G. D. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1796425 · Cited by 87
Structural Definition of a Neutralization-sensitive Epitope on the MERS-CoV S1-NTD
Wang, N., Rosen, O., Wang, L., Turner, H. L., Stevens, L. J., Corbett, K. S., Bowman, C. A., Pallesen, J., Shi, W., Zhang, Y., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.052 · Cited by 86
Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants
Li, T., Xue, W., Zheng, Q., Song, S., Yang, C., Xiong, H., Zhang, S., Hong, M., Zhang, Y., Yu, H. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25997-3 · Cited by 72
Bianchini, F., Crivelli, V., Abernathy, M. E., Guerra, C., Palus, M., Muri, J., Marcotte, H., Piralla, A., Pedotti, M., Gasparo, R. D., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.ade0958 · Cited by 88
Structural Basis of SARS-CoV-2 and SARS-CoV Antibody Interactions
Gavor, E., Choong, Y. K., Er, S. Y., Sivaraman, H., & Sivaraman, J. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.09.004 · Cited by 83
Wang, Y., Xu, C., Wang, Y., Qin, H., Zhang, C., Li, Z., Xu, S., Zuo, Q., Liu, C., Huang, Z. W., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27350-0 · Cited by 85
SARS-CoV-2 Entry Inhibitors: Small Molecules and Peptides Targeting Virus or Host Cells
Cannalire, R., Stefanelli, I., Cerchia, C., Beccari, A. R., Pelliccia, S., & Summa, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165707 · Cited by 84
Shah, M., Ahmad, B., Choi, S., & Woo, H. G. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.11.002 · Cited by 79
Contribution of single mutations to selected SARS-CoV-2 emerging variants spike antigenicity
Gong, S. Y., Chatterjee, D., Richard, J., Prévost, J., Tauzin, A., Gasser, R., Bo, Y., Vézina, D., Goyette, G., Gendron‐Lepage, G., et al. (2021) · Virology · doi:10.1016/j.virol.2021.09.001 · Cited by 81
Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit
Hurlburt, N. K., Homad, L. J., Sinha, I. R., Jennewein, M. F., MacCamy, A. J., Wan, Y.-H., Boonyaratanakornkit, J. B., Sholukh, A. M., Jackson, A. M., Zhou, P.-P., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03262-7 · Cited by 80
A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivo
Hanke, L., Das, H., Sheward, D. J., Vidakovics, L. P., Urgard, E., Moliner-Morro, A., Kim, C., Karl, V., Pankow, A. P., Smith, N. L., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27610-z · Cited by 80
Analysis of the SARS-CoV-2 spike protein glycan shield: implications for immune recognitionPreprint
Grant, O. C., Montgomery, D., Ito, K., & Woods, R. J. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.07.030445 · Cited by 87
Structure-based development of human antibody cocktails against SARS-CoV-2
Wang, N., Sun, Y., Feng, R., Wang, Y., Guo, Y., Zhang, L., Deng, Y., Wang, L., Cui, Z., Cao, L., et al. (2020) · Cell Research · doi:10.1038/s41422-020-00446-w · Cited by 81
COVID-19: an Immunopathological View
Kadkhoda, K. (2020) · mSphere · doi:10.1128/msphere.00344-20 · Cited by 80
Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies
Hussain, A., Hasan, A., Babadaei, M. M. N., Bloukh, S. H., Chowdhury, M. E. H., Sharifi, M., Haghighat, S., & Falahati, M. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110559 · Cited by 78
He, P., Liu, B., Gao, X., Yan, Q., Pei, R., Sun, J., Chen, Q., Hou, R., Li, Z., Zhang, Y., et al. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01235-4 · Cited by 76
Self-citationBowen, J. E., Park, Y., Stewart, C., Brown, J. T., Sharkey, W. K., Walls, A. C., Joshi, A., Sprouse, K. R., McCallum, M., Tortorici, M. A., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.adf1421 · Cited by 81
Self-citationSialoglycan binding triggers spike opening in a human coronavirus
Pronker, M. F., Creutznacher, R., Drulyte, I., Hulswit, R. J. G., Li, Z., van Kuppeveld, F. J. M., Snijder, J., Lang, Y., Bosch, B., Boons, G., et al. (2023) · Nature · doi:10.1038/s41586-023-06599-z · Cited by 82
Self-citationSun, C., Chen, L., Yang, J., Luo, C., Zhang, Y., Li, J., Yang, J., Zhang, J., & Xie, L. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.16.951723 · Cited by 77
Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins
Dang, H. V., Cross, R. W., Borisevich, V., Bornholdt, Z. A., West, B. R., Chan, Y., Mire, C. E., Silva, S. C. D., Dimitrov, A. S., Yan, L., et al. (2021) · Nature Structural & Molecular Biology · doi:10.1038/s41594-021-00584-8 · Cited by 76
Self-citationStructural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia
Asarnow, D. E., Wang, B., Lee, W.-H. S., Hu, Y., Huang, C.-W., Faust, B., Ng, P. M. L., Ngoh, E. Z. X., Bohn, M., Bulkley, D. P., et al. (2021) · Cell · doi:10.1016/j.cell.2021.04.033 · Cited by 75
Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape
Mast, F. D., Fridy, P. C., Ketaren, N. E., Wang, J., Jacobs, E. Y., Olivier, J. P., Sanyal, T., Molloy, K. R., Schmidt, F., Rutkowska, M., et al. (2021) · eLife · doi:10.7554/elife.73027 · Cited by 69
Structural and functional analysis of a potent sarbecovirus neutralizing antibody
Pinto, D., Park, Y., Beltramello, M., Walls, A. C., Tortorici, M. A., Bianchi, S., Jaconi, S., Culap, K., Zatta, F., Marco, A. D., et al. (2020) · Worldwide Protein Data Bank · doi:10.2210/pdb6ws6/pdb · Cited by 82
Self-citationImmunotherapeutic approaches to curtail COVID-19
Owji, H., Negahdaripour, M., & Hajighahramani, N. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106924 · Cited by 79
Verkhivker, G. M., Agajanian, S., Öztaş, D. Y., & Gupta, G. (2021) · Biochemistry · doi:10.1021/acs.biochem.1c00139 · Cited by 62
Roberts, D. S., Mann, M. W., Melby, J. A., Larson, E. J., Zhu, Y., Brasier, A. R., Jin, S., & Ge, Y. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c02713 · Cited by 75
Paola, L. D., Hadi‐Alijanvand, H., Song, X., Hu, G., & Giuliani, A. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00273 · Cited by 71
Ca2+-dependent mechanism of membrane insertion and destabilization by the SARS-CoV-2 fusion peptide
Khelashvili, G., Plante, A., Doktorova, M., & Weinstein, H. (2021) · Biophysical Journal · doi:10.1016/j.bpj.2021.02.023 · Cited by 73
Arashkia, A., Jalilvand, S., Mohajel, N., Afchangi, A., Azadmanesh, K., Salehi-Vaziri, ., Fazlalipour, M., Pouriayevali, M. H., Jalali, T., Nasab, S. D. M., et al. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2183 · Cited by 73
Ali, M. G., Zhang, Z., Gao, Q., Pan, M., Rowan, E. G., & Zhang, J. (2020) · Immunologic Research · doi:10.1007/s12026-020-09159-z · Cited by 71
Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions
Shiakolas, A. R., Kramer, K. J., Wrapp, D., Richardson, S. I., Schäfer, A., Wall, S. C., Wang, N., Janowska, K., Pilewski, K. A., Venkat, R., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100313 · Cited by 75
SARS-CoV-2: A Master of Immune Evasion
Rubio‐Casillas, A., Redwan, E. M. M. M., & Uversky, V. N. (2022) · Biomedicines · doi:10.3390/biomedicines10061339 · Cited by 72
Siriwattananon, K., Manopwisedjaroen, S., Shanmugaraj, B., Rattanapisit, K., Phumiamorn, S., Sapsutthipas, S., Trisiriwanich, S., Prompetchara, E., Ketloy, C., Buranapraditkun, S., et al. (2021) · Frontiers in Plant Science · doi:10.3389/fpls.2021.682953 · Cited by 68
Schön, M. P., Berking, C., Biedermann, T., Buhl, T., Erpenbeck, L., Eyerich, K., Eyerich, S., Ghoreschi, K., Goebeler, M., Ludwig, R. J., et al. (2020) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14169 · Cited by 67
Verkhivker, G. M. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00654 · Cited by 61
Fallon, L., Belfon, K. A. A., Raguette, L. E., Wang, Y., Stepanenko, D., Cuomo, A. E., Guerra, J., Budhan, S., Varghese, S., Corbo, C. P., et al. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c00556 · Cited by 64
Protein engineering strategies for rational immunogen design
Caradonna, T. M., & Schmidt, A. G. (2021) · npj Vaccines · doi:10.1038/s41541-021-00417-1 · Cited by 68
SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates
Li, T., Zheng, Q., Yu, H. J., Wu, D., Xue, W., Xiong, H., Huang, X., Nie, M., Yue, M., Rong, R., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1821583 · Cited by 67
A potent pan-sarbecovirus neutralizing antibody resilient to epitope diversification
Rosen, L. E., Tortorici, M. A., Marco, A. D., Pinto, D., Foreman, W. B., Taylor, A. L., Park, Y., Bohan, D., Rietz, T. A., Errico, J. M., et al. (2024) · Cell · doi:10.1016/j.cell.2024.09.026 · Cited by 67
Self-citationProactive vaccination using multiviral Quartet Nanocages to elicit broad anti-coronavirus responses
Hills, R. A., Tan, T. K., Cohen, A. A., Keeffe, J. R., Keeble, A. H., Gnanapragasam, P. N. P., Storm, K. N., Rorick, A. V., West, A. P., Hill, M. L., et al. (2024) · Nature Nanotechnology · doi:10.1038/s41565-024-01655-9 · Cited by 82
Verkhivker, G. M., & Paola, L. D. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c00395 · Cited by 55
Characterization of neutralizing antibodies from a SARS-CoV-2 infected individualPreprint
Seydoux, E., Homad, L. J., MacCamy, A. J., Parks, K. R., Hurlburt, N. K., Jennewein, M. F., Akins, N. R., Stuart, A. B., Wan, Y.-H., Feng, J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.12.091298 · Cited by 64
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
Park, Y.-J., Pinto, D., Walls, A. C., Liu, Z., De Marco, A., Benigni, F., Zatta, F., Silacci-Fregni, C., Bassi, J., Sprouse, K. R., et al. (2022) · doi:10.1101/2022.05.08.491108 · Cited by 251
Self-citationIsmail, S., Ahmad, S., & Azam, S. S. (2020) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2020.113612 · Cited by 63
Mutational Frequencies of SARS-CoV-2 Genome during the Beginning Months of the Outbreak in USA
Kaushal, N., Gupta, Y., Goyal, M., Khaiboullina, S. F., Baranwal, M., & Verma, S. C. (2020) · Pathogens · doi:10.3390/pathogens9070565 · Cited by 61
Verkhivker, G. M., & Paola, L. D. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c10637 · Cited by 56
The global population of SARS-CoV-2 is composed of six major subtypes
Morais, I. J., Polveiro, R. C., Souza, G. M., Bortolin, D. I., Sassaki, F. T., & Lima, A. T. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-74050-8 · Cited by 62
Giron, C. C., Laaksonen, A., & da Silva, F. L. B. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198021 · Cited by 63
Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design
Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020) · Vaccines · doi:10.3390/vaccines8030355 · Cited by 60
Onodera, T., Kita, S., Adachi, Y., Moriyama, S., Sato, A., Nomura, T., Sakakibara, S., Inoue, T., Tadokoro, T., Anraku, Y., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.08.025 · Cited by 61
Sybodies targeting the SARS-CoV-2 receptor-binding domainPreprint
Walter, J. D., Hutter, C. A. J., Zimmermann, I., Wyss, M., Egloff, P., Sorgenfrei, M., Hürlimann, L. M., Gonda, I., Meier, G., Remm, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.16.045419 · Cited by 58
Jin, X., Xu, K., Jiang, P., Lian, J., Hao, S., Yao, H., Jia, H., Zhang, Y., Zheng, L., zheng, N., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1781551 · Cited by 59
Potential inhibitors of the interaction between ACE2 and SARS-CoV-2 (RBD), to develop a drug
Benítez‐Cardoza, C. G., & Vique‐Sánchez, J. L. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117970 · Cited by 59
Design of the SARS-CoV-2 RBD vaccine antigen improves neutralizing antibody response
Dickey, T. H., Tang, W. K., Butler, B., Ouahes, T., Orr-Gonzalez, S., Salinas, N. D., Lambert, L., & Tolia, N. H. (2022) · Science Advances · doi:10.1126/sciadv.abq8276 · Cited by 59
Viral Architecture of SARS-CoV-2 with Post-Fusion Spike Revealed by Cryo-EMPreprint
Liu, C., Yang, Y., Gao, Y., Shen, C., Ju, B., Liu, C., Tang, X., Wei, J., Ma, X., Liu, W., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.02.972927 · Cited by 59
Distinct antibody repertoires against endemic human coronaviruses in children and adults
Khan, T., Rahman, M., Ali, F. A., Huang, S. S. Y., Ata, M. M. A., Zhang, Q., Bastard, P., Liu, Z., Jouanguy, E., Béziat, V., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.144499 · Cited by 56
Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2
Prévost, J., Richard, J., Gasser, R., Ding, S., Fage, C., Anand, S. P., Adam, D., Vergara, N. G., Tauzin, A., Benlarbi, M., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101151 · Cited by 64
The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants
Rothenberger, S., Hurdiss, D. L., Walser, M., Malvezzi, F., Mayor, J., Ryter, S., Moreno, H., Liechti, N., Bosshart, A., Iss, C., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01382-3 · Cited by 75
Mass Spectrometry-Based Structural Virology
Wörner, T. P., Shamorkina, T. M., Snijder, J., & Heck, A. J. R. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c04339 · Cited by 60
Self-citationRamos, S. G., Rattis, B. A. D. C., Giulia Ottaviani, M., Celes, M. R. N., & Dias, E. P. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.04.010 · Cited by 59
Computational design and modeling of nanobodies toward SARS‐CoV‐2 receptor binding domain
Yang, J., Zhang, Z., Yang, F., Zhang, H., Wu, H., Zhu, F., & Xue, W. (2021) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13847 · Cited by 56
Precision therapeutic targets for COVID-19
Krumm, Z. A., Lloyd, G. M., Francis, C. P., Nasif, L. H., Mitchell, D. A., Golde, T. E., Giasson, B. I., & Xia, Y. (2021) · Virology Journal · doi:10.1186/s12985-021-01526-y · Cited by 58
Neal, C. J., Fox, C. R., Sakthivel, T. S., Kumar, U., Fu, Y., Drake, C., Parks, G. D., & Seal, S. (2021) · ACS Nano · doi:10.1021/acsnano.1c04142 · Cited by 56
Fédry, J., Hurdiss, D. L., Wang, C., Li, W., Obal, G., Drulyte, I., Du, W., Howes, S. C., van Kuppeveld, F. J. M., Förster, F. G., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf5632 · Cited by 54
Karnik, M., Beeraka, N. M., Uthaiah, C. A., Nataraj, S. M., Bettadapura, A. D. S., Aliev, G., & Madhunapantula, S. V. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02399-6 · Cited by 56
Wang, S., Wang, J., Yu, X., Jiang, W., Chen, S., Wang, R., Wang, M., Jiao, S., Wang, W., Wang, W., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03207-0 · Cited by 57
Antibody dependent enhancement: Unavoidable problems in vaccine development
Xu, L., Ma, Z., Li, Y., Pang, Z., & Xiao, S. (2021) · Advances in immunology · doi:10.1016/bs.ai.2021.08.003 · Cited by 54
Metadata
- Authors
- Walls, A. C., Xiong, X., Park, Y.-J., Tortorici, M. A., Snijder, J., Quispe, J., Cameroni, E., Gopal, R., Dai, M., Lanzavecchia, A., Zambon, M., Rey, F. A., Corti, D., & Veesler, D.
- Affiliations
- University of Washington (US)
- Centre National de la Recherche Scientifique (FR)
- Vir Biotechnology (Switzerland) (CH)
- Public Health England (GB)
- The Francis Crick Institute (GB)
- Institute for Research in Biomedicine (CH)
- Corresponding author
- Veesler, David
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 176
- Issue
- 5
- Pages
- 1026-1039.e15
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC6751136
- OpenAlex
- W2915009278
- Cited by
- 582
- References
- 85
- Citations by year
- 2026: 7 · 2025: 25 · 2024: 30 · 2023: 40 · 2022: 79 · 2021: 173 · 2020: 214 · 2019: 14
- FWCI
- 92.33
- Type
- journal article
- Language
- en
- Update notices
- erratum (2020-12-10)
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Funders
- National Institute of General Medical Sciences (R01GM120553)
- National Institute of Allergy and Infectious Diseases (HHSN272201700059C)
- Pew Biomedical Scholars Award
- Burroughs Wellcome Fund
- Netherlands Organisation for Scientific Research (Rubicon 019.2015.2.310.006)
- European Molecular Biology Organization (ALTF933-2015)
- Zoonoses Anticipation and Preparedness Initiative (IMI115760)
- Pasteur Institute
- Centre National de la Recherche Scientifique
- LabEx Integrative Biology of Emerging Infectious Diseases
- University of Washington Arnold and Mabel Beckman CryoEM Center and Proteomics Resource (UWPR95794)
- Advanced Light Source at Lawrence Berkley National Laboratory
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Keywords
- SARS-CoV, MERS-CoV, neutralizing antibodies, antibody-antigen complex structure, humoral immune response, viral entry, receptor binding
- MeSH terms
- Animals, Antibodies, Monoclonal, Antibodies, Viral, Chlorocebus aethiops, Humans, Protein Binding, Receptors, Virus, Vero Cells, Coronavirus, Coronavirus Infections, Molecular Mimicry, Severe acute respiratory syndrome-related coronavirus, Virus Internalization, Immunity, Humoral, Antibodies, Neutralizing, HEK293 Cells, Spike Glycoprotein, Coronavirus, Middle East Respiratory Syndrome Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
